Stereotactic Ablative Radiotherapy With Nivolumab for Early-Stage Operable Non-Small Cell Lung Cancer
Condition: Non-small Cell Lung Cancer Stage I Intervention: Combination Product: nivolumab Sponsor: Hospital Israelita Albert Einstein Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials